"And as this winter draws to a close and spring starts blossoming, a lot
of these tradeables owners, if not already fretting, will, in all
likelihood, be increasingly irate at the lengthy period of management's
total silence regarding developments and the absence of any news that
might yet save the day for those tradeables."
I recall when I bought those warrants thinking that surely within 5 years this company would be able to capitalize on this drug. While I'm still hopeful that will be the case, it's not really based on anything beyond hope. We've gotten bits and pieces of seemingly good information, but that hasn't translated into anything of interest to the market. The kicker to me is that the drug does appear to work (to someone not skilled in this area) and yet the industry interest is moot. It would be nice to see our team push this across the line and get an initial approval to then see how this can help people.